APWM
ABBV icon

Argonautica Private Wealth Management’s AbbVie ABBV Stock Holding History

Argonautica Private Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26M Sell
14,979
-593
-4% -$132K 0.99% 29
2025
Q4 		$3.56M Sell
15,572
-428
-3% -$97.5K 1.04% 23
2025
Q3 		$3.7M Sell
16,000
-182
-1% -$37.1K 1.08% 21
2025
Q2 		$3M Sell
16,182
-405
-2% -$75.3K 0.95% 31
2025
Q1 		$3.48M Buy
16,587
+286
+2% +$55.6K 1.19% 21
2024
Q4 		$2.9M Sell
16,301
-30
-0.2% -$5.52K 0.94% 25
2024
Q3 		$3.22M Sell
16,331
-5,736
-26% -$1.07M 1.07% 23
2024
Q2 		$3.78M Buy
22,067
+113
+0.5% +$18.7K 1.3% 17
2024
Q1 		$4M Buy
21,954
+452
+2% +$77.9K 1.43% 16
2023
Q4 		$3.33M Buy
21,502
+181
+0.8% +$26.4K 1.37% 17
2023
Q3 		$3.18M Buy
21,321
+75
+0.4% +$11K 1.43% 18
2023
Q2 		$2.86M Buy
21,246
+757
+4% +$111K 1.29% 21
2023
Q1 		$3.27M Buy
20,489
+14,218
+227% +$2.17M 1.65% 13
2022
Q4 		$1.01M Buy
+6,271
New +$962K 0.52% 45

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argonautica Private Wealth Management's ABBV Position: Q1 2026 in Review

Argonautica Private Wealth Management reduced its AbbVie (ABBV) stake by 3.8% in Q1 2026, selling an estimated $132K and leaving 14,979 shares worth $3.26M. The position accounts for 0.99% of the portfolio, ranked #29.

Argonautica Private Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $4M in Q1 2024. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Argonautica Private Wealth Management held 14,979 shares of AbbVie worth $3.26M as of Q1 2026.
  • Argonautica Private Wealth Management sold 593 AbbVie shares in Q1 2026, an estimated $132K.
  • AbbVie made up 0.99% of Argonautica Private Wealth Management's portfolio in Q1 2026, its #29 holding.
  • Argonautica Private Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • Argonautica Private Wealth Management's AbbVie position peaked at $4M in Q1 2024.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.